Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 11 - 16 save search
CNH Industrial to announce an Iveco Group Investor Day on November 18, 2021
Published: 2021-11-16 (Crawled : 22:00) - globenewswire.com
CNHI | News | $12.36 -1.51% -0.08% 8M
|
Producer Manufacturing
|
| O: -0.19%
H: 0.0%
C: 0.0%
trial
Atea Pharmaceuticals Provides Update on Strategic Collaboration with RocheAtea to lead global clinical trial development of AT-527 and regain ex-US commercial rights
Published: 2021-11-16 (Crawled : 22:00) - biospace.com/
AVIR | $3.71 -0.8% -0.81% 250K
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
at-527 collaboration trial
INDUS Announces Closing on the Acquisition of an Industrial/Logistics Building in Charleston, South Carolina
Published: 2021-11-16 (Crawled : 22:00) - globenewswire.com
INDT 4 | $66.99 0.02% 0.0% 0
|
Real Estate and Rental and Leas...
|
| O: -0.42%
H: 0.98%
C: 0.98%
acquisition trial
Nasal Vaccine Starts Trial to Protect Against Alzheimer's
Published: 2021-11-16 (Crawled : 18:00) - biospace.com/
IMAB | $1.81 1.12% 1.1% 390K
|
Health Technology
|
| O: 3.64%
H: 0.0%
C: 0.0%
alzheimer vaccine trial alzheimer’s alzheimer's
PolyPid Appoints New Oncology Advisory Board MemberCompany is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate Phase 1/2 Clinical Trial of OncoPLEX for Brain Tumors in 2022
Published: 2021-11-16 (Crawled : 16:00) - biospace.com/
PYPD | $4.45 3.29% 1.1K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
fda phase 1 potential trial train
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2021-11-16 (Crawled : 15:30) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
QTRX | $15.75 -1.19% -1.21% 480K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -1.52%
disease alzheimer clinical trials trials technology research trial conference alzheimer’s alzheimer's disease alzheimer's
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2021-11-16 (Crawled : 15:00) - biospace.com/
MYMD | $2.1 0.0% 45K
|
Manufacturing
|
| O: 1.11%
H: 1.41%
C: -12.72%
fda phase 2 clearance trial
SFIO signs US$100-M Agreement with Omnicor Industrial Estate & Realty Center to Develop a Resort Condotel in Batangas, Philippines
Published: 2021-11-16 (Crawled : 15:00) - globenewswire.com
SFIO | $0.0031 56.67% 1.3M
|
Manufacturing
|
| O: 2.84%
H: 17.24%
C: -12.07%
trial
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes-Initiation of patient enrollment expected by year-end-
Published: 2021-11-16 (Crawled : 14:00) - biospace.com/
CRSP M | $55.56 -4.14% -4.32% 1.4M
|
Health Technology
|
| O: -5.24%
H: 0.0%
C: 0.0%
crispr diabetes treatment therapy trial enroll
Allied Corp Progresses Towards Clinical Phase I Trial for Psilonex™ RX Psilocybin Pharma Drug
Published: 2021-11-16 (Crawled : 14:00) - globenewswire.com
ALID | $0.1797 -73.85% 6.7K
|
Manufacturing
|
| O: 0.0%
H: 0.96%
C: 0.72%
drug trial pharma psilocybin
INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201
Published: 2021-11-16 (Crawled : 13:30) - inovio.com
INO 2 d | $11.05 14.69% 12.81% 700K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
vaccine trial
Oncotelic Announces Successful Completion of the Safety Evaluation of a TGF-β Inhibitor (OT-101) and IL-2 (Aldesleukin) in Phase 1 Combination Trial in Solid Tumor Cancers
Published: 2021-11-16 (Crawled : 13:30) - globenewswire.com
OTLC | $0.0411 -44.63% 21K
|
Manufacturing
|
| O: 4.26%
H: 8.42%
C: 5.92%
phase 1 cancer trial
NAES Corporation Partners with ABS Consulting to Strengthen Industrial Cybersecurity in the Power and Energy Sector
Published: 2021-11-16 (Crawled : 13:00) - prnewswire.com
ITOCF | $42.36 3.01% 2.6K
|
Distribution Services
|
| O: -1.33%
H: 0.2%
C: -0.24%
ITOCY | $86.07 0.0% 34K
|
Real Estate and Rental and Leas...
|
| O: 0.13%
H: 0.25%
C: 0.01%
security energy cybersecurity trial
Global Industrial IoT Market Research Report (2021 to 2026) - by Technology, Industry and Region
Published: 2021-11-16 (Crawled : 13:00) - prnewswire.com
ABLZF | News | $45.05 -32.74% 2.5K
|
Producer Manufacturing
|
| O: -2.07%
H: 0.77%
C: 0.77%
ROK | $278.65 -0.97% 0.0% 820K
|
Producer Manufacturing
|
| O: 0.18%
H: 2.4%
C: 1.55%
IBM | News | $183.1 -0.35% 0.0% 3M
|
Technology Services
|
| O: -0.65%
H: 0.82%
C: -0.39%
HON | News M | $190.32 -0.21% -0.21% 2.2M
|
Producer Manufacturing
|
| O: 0.0%
H: 0.3%
C: -0.56%
GE | $155.67 -0.7% -0.36% 6.5M
|
Electronic Technology
|
| O: -1.86%
H: 0.06%
C: -2.64%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: -0.48%
H: 0.96%
C: 0.6%
PTC | $177.46 -0.65% -0.65% 760K
|
Technology Services
|
| O: -2.17%
H: 0.0%
C: 0.0%
INTC | $35.66 -1.65% -1.68% 41M
|
Electronic Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
CSCO | News | $47.78 -0.29% -0.29% 14M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
ANSS | $325.5 -0.4% -0.4% 210K
|
Technology Services
|
| O: 0.52%
H: 0.0%
C: 0.0%
technology research iot trial
Kforce Inc. announces participation in the Truist Securities Industrials and Services Summit
Published: 2021-11-16 (Crawled : 13:00) - globenewswire.com
KFRC | $63.42 -1.51% -1.53% 52K
|
Commercial Services
|
| O: -0.18%
H: 0.0%
C: 0.0%
trials trial
NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials
Published: 2021-11-16 (Crawled : 12:00) - biospace.com/
NNVC | $1.16 -1.7% 0.0% 7.7K
|
Health Technology
|
| O: -6.11%
H: 0.0%
C: 0.0%
clinical trials trials drug trial
Codiak Reports Positive Initial Data for exoSTING™ Phase 1/2 Trial Indicating Tolerability, Immune Activation, and Evidence of Tumor Shrinkage in Injected and Non-Injected Tumors in the First Three Dose Escalation Cohorts
Published: 2021-11-16 (Crawled : 12:00) - globenewswire.com
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: 0.0%
phase 1 positive trial injection
Canoo Selects Northwest Arkansas for its Headquarters, R&D Center and EV Industrialization Facility
Published: 2021-11-15 (Crawled : 00:00) - prnewswire.com
GOEV A | $2.85 -2.73% -2.81% 9M
|
|
| O: 0.12%
H: 22.96%
C: 21.79%
trial
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.